Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)

NCT02676544 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT02676544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02676544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)
Lead sponsor
Rhode Island Hospital
Phase
Phase 1/2
Overall status
Terminated
Start date
December 31, 2015
Completion date
June 30, 2021
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hypertrophy, lower urinary tract symptoms